Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-5,643,716
Closed -$41M 204
2018
Q1
$41M Buy
5,643,716
+135,675
+2% +$933K 0.65% 26
2017
Q4
$35.6M Buy
5,508,041
+41,256
+0.8% +$264K 0.56% 39
2017
Q3
$36M Buy
5,466,785
+271,009
+5% +$1.68M 0.54% 42
2017
Q2
$28.5M Buy
5,195,776
+38,476
+0.7% +$219K 0.47% 50
2017
Q1
$29.7M Buy
5,157,300
+613,537
+14% +$3.37M 0.43% 61
2016
Q4
$22.3M Buy
4,543,763
+815,805
+22% +$4.4M 0.33% 77
2016
Q3
$22.7M Sell
3,727,958
-910,242
-20% -$5.44M 0.29% 82
2016
Q2
$24M Buy
+4,638,200
New +$24.9M 0.43% 74
2014
Q3
Sell
-3,395,805
Closed -$23.9M 146
2014
Q2
$23.9M Buy
3,395,805
+745,800
+28% +$5.49M 0.42% 72
2014
Q1
$19.6M Buy
2,650,005
+644,240
+32% +$4.51M 0.37% 79
2013
Q4
$14.7M Buy
+2,005,765
New +$14.7M 0.27% 100

Other funds holding ABEV

Howard Marks's ABEV Position: Q2 2018 in Review

Howard Marks sold out of Ambev (ABEV) in Q2 2018, closing a stake of 5,643,716 shares — an estimated $41M sold.

Howard Marks first reported a position in ABEV in Q4 2013 and held it in 11 quarters. The position peaked at $41M in Q1 2018. 337 funds tracked by Wall St. Rank hold ABEV as of Q2 2018.

  • Howard Marks reported no remaining Ambev position as of Q2 2018 after selling out during the quarter.
  • Howard Marks sold 5,643,716 Ambev shares in Q2 2018, an estimated $41M.
  • Howard Marks first reported a position in Ambev in Q4 2013 and held it in 11 quarters.
  • Howard Marks's Ambev position peaked at $41M in Q1 2018.
  • 337 funds tracked by Wall St. Rank held Ambev as of Q2 2018.

Based on Oaktree Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.